000 01640 a2200481 4500
005 20250516220512.0
264 0 _c20140918
008 201409s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/apt.12842
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeszthelyi, D
245 0 0 _aSerotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_cAug 2014
300 _a392-402 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _a5-Hydroxytryptophan
_xadministration & dosage
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aCase-Control Studies
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxyindoleacetic Acid
_xmetabolism
650 0 4 _aIntestinal Mucosa
_xmetabolism
650 0 4 _aIntestines
_xphysiopathology
650 0 4 _aIrritable Bowel Syndrome
_xphysiopathology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSerotonin
_xmetabolism
650 0 4 _aTight Junctions
_xmetabolism
650 0 4 _aYoung Adult
700 1 _aTroost, F J
700 1 _aJonkers, D M
700 1 _avan Eijk, H M
700 1 _aLindsey, P J
700 1 _aDekker, J
700 1 _aBuurman, W A
700 1 _aMasclee, A A M
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 40
_gno. 4
_gp. 392-402
856 4 0 _uhttps://doi.org/10.1111/apt.12842
_zAvailable from publisher's website
999 _c23932268
_d23932268